Salah Nermin, Abd El Dayem Soha M, El Mogy Fatma, Amin Maha, Ibrahim Marwa
Pediatrics Department, Cairo University, Cairo, Egypt.
J Pediatr Endocrinol Metab. 2013;26(3-4):257-69. doi: 10.1515/jpem-2012-0091.
To study growth response to growth hormone (GH) treatment in growth hormone-deficient (GHD) patients.
In total, 477 GHD children were included in the study. Patients were followed up for a minimum of 1 year and up to 6 years, anthropometric assessment was performed every 3 months, while thyroid profile was followed every 6 months. Student's t-test was used for analysis of two quantitative variables.
Patients with complete GHD and multiple pituitary hormone deficiency were significantly shorter as expressed in their height standard deviation score (SDS), target height - height (SDS) and a more bone age delay. Patients with complete GHD showed better growth response compared with those with partial GHD in the first 2 years of therapy.
We conclude that anthropometric assessment is the cornerstone in GHD diagnosis and follow-up, where catch up growth occurs in the first 2 years of therapy followed by a plateau.
研究生长激素缺乏症(GHD)患者对生长激素(GH)治疗的生长反应。
本研究共纳入477例GHD儿童。患者随访至少1年,最长6年,每3个月进行一次人体测量评估,每6个月监测一次甲状腺功能。采用学生t检验分析两个定量变量。
完全性GHD和多种垂体激素缺乏的患者身高标准差评分(SDS)、目标身高-身高(SDS)显著更低,骨龄延迟更明显。在治疗的前2年,完全性GHD患者比部分性GHD患者表现出更好的生长反应。
我们得出结论,人体测量评估是GHD诊断和随访的基石,在治疗的前2年出现追赶生长,随后进入平台期。